SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-136925
Filing Date
2021-11-10
Accepted
2021-11-10 16:05:29
Documents
13
Period of Report
2021-11-04
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2132495d1_8k.htm   iXBRL 8-K 26707
2 EXHIBIT 10.1 tm2132495d1_ex10-1.htm EX-10.1 8002
  Complete submission text file 0001104659-21-136925.txt   211400

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA osmt-20211104.xsd EX-101.SCH 3189
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE osmt-20211104_lab.xml EX-101.LAB 34594
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE osmt-20211104_pre.xml EX-101.PRE 22713
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2132495d1_8k_htm.xml XML 3611
Mailing Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807
Business Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807 9088091300
Osmotica Pharmaceuticals plc (Filer) CIK: 0001739426 (see all company filings)

IRS No.: 000000000
Type: 8-K | Act: 34 | File No.: 001-38709 | Film No.: 211396496
SIC: 2834 Pharmaceutical Preparations